GPC Biotech Is the First German Biotech Company to Adopt Voluntary Corporate Governance Principles
GPC Biotech AG (Neuer Markt Frankfurt: GPC) is the first biotech company listed on the German Neuer Markt to voluntarily approve corporate governance principles that go beyond the requirements of law. GPC Biotech has thus established a clear set of rules covering all aspects of responsible corporate management and corporate control that are driven by value growth. These principles include the protection of shareholders' rights, comprehensive disclosure and transparency requirements, and rules governing conflicts of interest and own-account transactions.
"Our corporate governance principles are a clear expression of our commitment and our responsibility to all stakeholders on a national and international level," commented Bernd R. Seizinger, M.D., Ph.D., President and CEO of GPC Biotech. "In complex industries such as biotechnology, corporate governance principles are particularly important to reinforce a company's commitment towards value creation."
GPC Biotech's corporate governance principles are based on the OECD Principles for Corporate Governance and the Code of Best Practice of the German Panel on Corporate Governance. In addition, GPC Biotech has carried out an evaluation using the Scorecard of the Working Group of the German Association of Financial Analysts and Asset Management (DVFA). The achieved score of 88 % is an excellent result relative to a positive evaluation of corporate governance which is given at 67 % using the Scorecard.
The GPC Biotech Corporate Governance Principles and the summary of the results of the Scorecard evaluation can be viewed on GPC Biotech's homepage www.gpc-biotech.com under Investors/Corporate Governance.
Most read news
Other news from the department science

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
WorleyParsons awarded Evonik contract

Building-Kit Catalyst - Metal-free organic framework for electrocatalytic production of ethylene from carbon dioxide

Found: The ‘holy grail of catalysis’ - Turning methane into methanol under ambient conditions using light
A cooler way to protect silicon surfaces - New room-temperature process could lead to less expensive solar cells and other electronic devices
BP and NOVA Chemicals sign binding agreements for European Styrenics Joint Venture

A new spin in nano-electronics - Researchers succeed in controlling extremely short-wavelength spin waves
SCHOTT to Open New Production Site for High Quality Pharmaceutical Packaging in China
Protecting Plastics and Rubber: Ceresana Analyzes the Stabilizer Market

Acids, Alkalis, and the pH Scale
